We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 5,073 results
  1. Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma

    The objective of this study was to analyze the expression and prognostic role of the tight junction protein claudin-10 in high-grade serous carcinoma...

    Ben Davidson, Delfim Doutel, ... Dag Andre Nymoen in Virchows Archiv
    Article Open access 17 April 2023
  2. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1

    Background

    Lymph node metastasis (LNM) is a major factor contributing to the high mortality rate of ovarian cancer, making the treatment of this...

    Jiajia Li, Yihua Sun, ... Mo Chen in Journal of Ovarian Research
    Article Open access 14 March 2024
  3. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer

    Background

    Aberrant expression of microRNAs (miRNAs) contributes to the development of high grade serous ovarian cancer (HGSOC). However, the...

    **aoyuan Lu, Guilin Li, ... Buze Chen in Journal of Ovarian Research
    Article Open access 08 July 2021
  4. The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study

    Background

    Women with advanced-stage high-grade serous ovarian cancer (HGSOC) are likely to have a bad prognosis. Relapses are common in patients even...

    Qiao Wang, Ying Zheng, ... Zhilan Peng in Journal of Ovarian Research
    Article Open access 20 December 2021
  5. Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer

    Purpose

    Sphingosine-kinase-1 (SPHK1) is a key enzyme of sphingolipid metabolism which is involved in ovarian cancer pathogenesis, progression and...

    L. C. Hanker, A. El-Balat, ... F. Hoellen in Journal of Cancer Research and Clinical Oncology
    Article Open access 03 March 2021
  6. Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes

    Circulating leukocytes are an important part of the immune system. The aim of this work is to explore the role of preoperative circulating leukocytes...

    Ying Feng, Zhixiang Wang, ... Zhenyu Zhang in Journal of Ovarian Research
    Article Open access 24 May 2022
  7. Risk-reducing sal**o-oophorectomy among Chinese women at increased risk of breast and ovarian cancer

    Background

    Risk-reducing sal**o-oophorectomy (RRSO) is recommended for women at increased risk of breast and ovarian cancer. We launched a...

    Zheng Feng, Ke Zuo, ... **aohua Wu in Journal of Ovarian Research
    Article Open access 29 June 2023
  8. Identification of potentially actionable genetic variants in epithelial ovarian cancer: a retrospective cohort study

    Ovarian cancer is the most lethal gynecologic malignancy, mainly due to late-stage diagnosis, frequent recurrences, and eventually therapy...

    Charlotte Fieuws, Joni Van der Meulen, ... Kathleen B. M. Claes in npj Precision Oncology
    Article Open access 22 March 2024
  9. Mixed high-grade serous and large cell neuroendocrine carcinoma arising from rectal endometriosis 11 years after hysterectomy

    The malignant gastrointestinal endometriosis transformation is represented by endometriosis-associated intestinal tumors. Endometrioid adenocarcinoma...

    Takumi Yanagita, Takuto Hikichi, ... Hiromasa Ohira in Clinical Journal of Gastroenterology
    Article 10 February 2023
  10. High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer

    Background

    Taxol resistance in serous ovarian cancer is responsible for its poor prognosis, yet the underlying mechanism is still poorly understood....

    Yuqing Shen, Hui Lin, ... Weiguo Lu in Journal of Ovarian Research
    Article Open access 27 April 2022
  11. Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report

    Background

    At the time of benign gynecological surgery, a prophylactic sal**o-oophorectomy or sal**ectomy is increasingly being performed...

    Hikaru Murakami, Satoe Fujiwara, ... Masahide Ohmichi in Journal of Medical Case Reports
    Article Open access 18 August 2023
  12. Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems

    Epithelial ovarian cancer (EOC) research has become more complex as researchers try to fully understand the metastatic process. Especially as we...

    Emily Tomas, Trevor G. Shepherd in Journal of Ovarian Research
    Article Open access 11 April 2023
  13. The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

    Background

    Ovarian serous cystadenocarcinoma, accounting for about 90% of ovarian cancers, is frequently diagnosed at advanced stages, leading to...

    Hao Qin, Jie Liu, ... Yi-Fang Yan in Journal of Ovarian Research
    Article Open access 05 July 2024
  14. Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium

    Background

    This study seeks to evaluate the impact of breast cancer ( BRCA ) gene status on tumor dissemination pattern, surgical outcome and survival...

    Jacek Glajzer, Dan Cacsire Castillo-Tong, ... Elena Ioana Braicu in Annals of Surgical Oncology
    Article Open access 09 September 2022
  15. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers

    Peritoneal metastasis is a common issue in the progression of high-grade serous ovarian cancers (HGSOCs), yet the underlying mechanism remains...

    Yiying Li, He Fei, ... Hua Jiang in Oncogene
    Article Open access 01 July 2021
  16. A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma

    Background

    Serous endometrial intraepithelial carcinoma (SEIC) is now considered to represent an early stage of uterine serous carcinoma (USC). It is...

    Maho Shimizu, Keitaro Yamanaka, ... Yoshito Terai in Journal of Ovarian Research
    Article Open access 29 June 2021
  17. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study

    Background

    Ovarian clear cell carcinoma (OCCC) is a rare pathological histotype in ovarian cancer, while the survival rate of advanced OCCC (Stage...

    Tingwei Liu, Yueqing Gao, ... Shaohua Xu in Journal of Ovarian Research
    Article Open access 01 June 2024
  18. Differences in the position of endometriosis-associated and non-associated ovarian cancer relative to the uterus

    Background

    Preoperative assessment of the histological type of ovarian cancer is essential to determine the appropriate treatment strategy. Tumor...

    Tsukasa Saida, Kensaku Mori, ... Takahito Nakajima in Insights into Imaging
    Article Open access 15 August 2023
  19. High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options

    Although many recent advancements have been made in women’s health, perhaps one of the most neglected areas of research is the diagnosis and...

    Yusuke Matoba, Kyle M. Devins, ... Bo R. Rueda in Reproductive Sciences
    Article 24 April 2024
  20. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

    Background

    The aim of this study was to evaluate the clinicopathological factors and prognosis of mucinous carcinoma (MC) with infiltrative invasion,...

    Taira Hada, Morikazu Miyamoto, ... Masashi Takano in Diagnostic Pathology
    Article Open access 20 January 2022
Did you find what you were looking for? Share feedback.